LakeShore Biopharma Co., Ltd (LSB)

LakeShore Biopharma Balance Sheet

Financials in millions CNY. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	222.61	370.37	271.07	390.46
Cash & Cash Equivalents	222.61	370.37	271.07	390.46
Cash Growth	-	36.63%	-30.58%	-
Receivables	403.12	463.05	308.56	256.05
Inventory	178.66	185.38	166.51	81.44
Other Current Assets	22.21	17.18	18.64	5.26
Total Current Assets	826.61	1,036	764.76	733.2
Property, Plant & Equipment	568.83	582.89	565	253.45
Goodwill and Intangibles	72.94	78.06	80.72	83.78
Other Long-Term Assets	42.05	22.83	31.27	96.74
Total Long-Term Assets	683.82	683.78	676.99	433.97
Total Assets	1,510	1,720	1,442	1,167
Accounts Payable	77.54	80.44	30.81	16.38
Deferred Revenue	23.85	25.9	32.35	33.01
Current Debt	428.98	198.49	116.06	3.79
Other Current Liabilities	352.48	353.93	296.7	291.87
Total Current Liabilities	882.85	658.76	475.91	345.04
Long-Term Debt	129.11	300.14	264.53	14.65
Other Long-Term Liabilities	23.96	32.4	30.05	30.88
Total Long-Term Liabilities	153.07	332.54	294.59	45.54
Total Liabilities	1,036	991.3	770.5	390.58
Total Debt	558.09	498.63	380.59	18.44
Debt Growth	-	31.02%	1963.98%	-
Retained Earnings	-2,126.33	-1,874.04	-1,590.57	-1,353.9
Comprehensive Income	-56.06	-54.41	83.09	44.22
Shareholders' Equity	474.51	728.45	-698.97	-508.86
Net Cash / Debt	-335.48	-128.26	-109.52	372.02
Net Cash Per Share	-	-1.38	-1.77	6.02
Working Capital	-56.24	377.22	288.85	388.16
Book Value Per Share	5.10	7.83	-11.30	-8.23

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).